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ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Authors’ reply to Cortese
Laura Batstra assistant professor1, Rae Thomas senior research fellow2, Geoffrey Mitchell professor
of general practice and palliative care 3
1University of Groningen, 9712 TJ, Groningen, Netherlands; 2Centre for Research in Evidence-Based Practice, Bond University, 4229 Australia;
3School of Medicine, University of Queensland, 4072 Australia
We recently expressed our concern that changing the age of
onset criterion for attention-deficit/hyperactivity disorder
(ADHD) from 7 to 12 years in the Diagnostic and Statistical
Manual of Mental Disorders, fifth edition (DSM-5) might
increase the risk of misdiagnosing pubertal restlessness and
distractibility as ADHD.1Cortese thinks that this is not supported
by empirical evidence,2 and he refers to a prospective study
which showed that such a change would increase the prevalence
of ADHD by only 0.1%.3
The ideal diagnostic criteria should minimise the risk of both
overdiagnosis and underdiagnosis (a false negative diagnosis).
The problem is that increases in diagnosis can greatly exceed
predictions when criteria are changed and drug companies get
involved.4 In the words of Allen Frances, chair of DSM-IV,
“The thing I learned with DSM-IV is that if anything can be
misused, it will be.”5
The required age of onset of 7 years was not set arbitrarily.
DSM-III and its text revision introduced this criterion to avoid
misdiagnosing children who react to school stress with
inattention, hyperactivity, and impulsivity.3 Extending the age
of onset to 12 years increases the risk of mistaking bad schooling
for ADHD.
We acknowledge that most people diagnosed as adults do not
recall onset before 7 years but do recall onset under 12 years.6
However, a prospective study concluded that retrospective
diagnoses of childhood ADHDmade on the basis of self reports
are mostly invalid in settings such as epidemiological surveys
and primary care facilities.7
We must get this right. In the US population of 300 million, a
seemingly negligible 0.1% increase in prevalence would result
in 300 000 new cases.4 In the UK (population 60 million), the
number of new cases would be 60 000. DSM-5 criteria must be
handled with care.
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